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Abstract 
Background: The purpose of this randomized, single-center study was to 
prospectively investigate the impact of anesthetic techniques for craniotomy on 
the release of cytokines (interleukin (IL)-1, IL-6, tumor necrosis factor factor-
alpha (TNF-α)) and to determine whether intravenous anesthesia compared to 
inhalational anesthesia attenuates the inflammatory response. 
Methods and Materials: The study enrolled 60 patients undergoing 
craniotomy, allocated into two equal groups to receive either Isoflurane (n=30) 
and Propofol (n=30). Non-invasive hemodynamic monitoring was used. 
Serum levels of IL-1, IL-6 and TNF-α were evaluated before and at the end of 
surgery and anesthesia. 
Results: Although there was a significant rise in serum level of inflammatory 
cytokine but compared with patients anaesthetized with Isoflurane, patients 
who received Propofol had significant lower levels of IL-1, IL-6 and TNF-a 
after surgery (p<0.05). 
Conclusion: Patients who received Propofol had lower levels of IL-1, IL-6 and 
TNF-α after surgery. Our findings should incite future studies to prove a 
potential medically important anti-inflammatory role of Propofol in 
neuroanesthesia. 
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Introduction 
Surgery and anesthesia can be associated with 
immune system modulation and may affect cell-
mediated immune balance and increased risk of 
postoperative complications such as sepsis and 
multiple organ damage (1-4). Studies have shown the 
release of catecholamines as part of the sympathetic 
response of the nervous system in a body following 
surgery and subsequent physiological stresses. 
Glucocorticoids also are secreted in the same manner 
during surgery as component of the hypothalamic-
pituitary-adrenal axis in the body (5). On the other 
hand, recent studies have demonstrated that the tissue 
damage following surgical incision increases the pre-
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inflammatory cytokines such as interleukin 1 (IL-1), 
IL-6 and tumor necrosis factor-alpha (TNF-α), in turn 
enhancing the activity of the hypothalamic-pituitary-
adrenal axis and the secretion of glucocorticoids (6, 7).  
There is a balance between the release of pro 
and anti-inflammatory cytokines. Inflammatory 
reactions that induced by immune cells can cause 
exacerbation of the pro-inflammatory response and 
increase the incidence of postoperative complications 
including; infections, delayed surgical wound healing, 
cognitive impairment and even progression of 
malignancies, systemic inflammatory response 
syndrome (SIRS), also lead to severe hemodynamic 
disorders and multiple organ failure (8-11).  
Human brain is particularly susceptible to 
oxidative damage compared with other body organs. 
The brain naturally intakes 20% of the total blood 
oxygen content and thus the highest levels of oxygen 
metabolites flow into the bloodstream of the brain. 
Various studies have shown that exposing the brain to 
any oxidative stress such as craniotomy can increase 
brain damage due to the low antioxidant capacity and 
high levels of oxygen consumed in the brain (12). 
Recently it has been confirmed that appropriate 
anesthetics can modulate the complex reactions of the 
patient's immune system during major surgery (8). 
Studies have shown that some injectable and inhaled 
anesthetics can modulate the immune system response 
through affecting multiple receptors and ionic channels 
in leukocytes (13-15). 
Propofol has been shown to be one of the most 
widely used anesthetics in various experimental 
studies with anti-inflammatory effects. These effects 
have been seen in other medications, including 
Isoflurane (16-18). However, various studies have 
conducted to compare the effects of Propofol and 
Isoflurane to survey different outcomes. There is a 
controversy about the degree of effectiveness of these 
two drugs (19-21). 
Considering effects of anesthetics during 
surgical anesthesia such as craniotomy can be one of 
the most effective therapeutic strategies against the 
reduction in the oxidative stress and subsequent 
complications. Although recent studies have indicated 
that many anesthetics have anti-inflammatory effects 
in experimental models, attention has been diverted to 
their pharmacological and pharmacokinetic aspects in 
the use of these drugs and there is no study to verify 
their effect on inflammatory and antioxidant processes 
during brain surgery (21). The aim of this study was to 
compare the influence of intravenous Propofol with 
Isoflurane anesthesia on plasma concentrations of pro- 
and anti-inflammatory cytokines (IL-1, IL-6 and TNF-
α) in patients undergoing craniotomy due to 
supratentorial tumor surgery. 
Methods 
After obtaining approval from the ethics 
committee of Shahid Beheshti University of Medical 
Sciences (SBMU), this clinical trial was conducted on 
patients who were candidate for craniotomy 
(supratentorial brain tumors) referring to Loghman 
Hakim Hospital, Tehran, Iran. Inclusion criteria 
included patients 18-65 years, ASA Class I and II, no 
history of rheumatic diseases or anti-inflammatory 
drugs. 
Exclusion criteria in this study were history of 
hypersensitivity to the drugs used in the study, patients 
taking beta-blocker medications or calcium channel 
blockers and anti-inflammatory vitamin supplements, 
surgery duration less than an hour, intraoperative need 
for blood transfusion over four packed cell units.  
After selecting patients, explaining the 
methodology and objectives of the study, written 
informed consent was obtained from patients and then 
they were randomly divided into two groups, 
anesthesia with Propofol and Isoflurane. The study 
included 60 patients, 20 in the Propofol group and 20 
in the Isoflurane group (Figure 1). 
Routine supportive interventions such as 
measuring blood pressure, electrocardiography (ECG) 
monitoring, measuring peripheral oxygen saturation by 
pulse oximeter in the operating room were performed 
for all patients. 
After taking the required blood samples and 
establishing IV line and oxygenation of patients with 
100% oxygen for 3 minutes, patients in both groups 
experienced induction of anesthesia in the following 
way; Midazolam 0.02 to 0.03 mg/kg, Fentanyl 2 to 6 
µg/kg, Propofol 1 to 5.2 mg/kg, Lidocaine 1 to 5.1 
mg/kg, Cisatracurium 0.1 mg/kg. After induction, the 
anesthesia was maintained using Propofol infusion 
with a dose of 100 to 200 μg/kg/min in one group and 
2.1% Isoflurane gas for the other group. 
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The blood pressure and heart rate were 
decreased to 20% of the baseline level during 
anesthesia. If the heart rate reached less than 45 bpm, 
it would be considered as bradycardia and the patients 
would receive 0.5mg of atropine, if needed. 
The intravascular crystalloid fluid was also 
injected to the patients by reducing the mean arterial 
pressure to 20% of the baseline level, and if not 
effective, 5 mg of ephedrine was added. 
In this study, 5 mL of venous blood was taken 
from all patients prior to anesthesia induction and after 
the completion of surgery in the recovery ward to 
determine the levels of TNF-α, IL-1 and IL-6 
cytokines. The blood samples were transferred to the 
lab to check the level of interleukins desired and kept 
at laboratory for about 30 min to form a clot. The serum 
was then separated by centrifugation at 2500 rpm for 
30 min, transferred to plastic test tubes, kept at -20°C 
to maintain by 6 months and at -70°C to maintain over 
6 months. The samples with 0°C temperature were 
transferred to Immunology Department lab SBMU to 
assess using ELISA assay (Bender MedSystems 
GmbH, Campus Vienna Biocenter 2, 1030 Vienna, 
Austria) measured interleukins with a sensitivity of 0.5 
to 1μg/l.  
Statistical analysis: two-tailed t-test with unequal 
variances and Chi-square test were used to test the 
differences in demographic data, duration of the 
procedure and anesthesia, drug consumption, fluid 
balance and hemodynamic parameters. Independent T-
test was used to compare the differences in cytokines 
mean values. Results were analyzed using SPSS 
software, version 16.0 (SPSS Inc., Chicago, IL, USA). 
Results 
None of the patients had signs of preoperative 
infection. All patients underwent craniotomy for the 
first time because of supratentorial tumor. No 
significant difference was found between the groups in 
demographics, underlying pathology, position during 
surgery, length of hospitalization and intraoperative 
variables (Tables 1 & 2). 
Patients who received Propofol showed 
statistically significant decrease in IL-1, IL-6 and TNF-
α sera level at the end of surgery (p=0.001, p=0.04 and 
p=0.01) (Table 3). 
Discussion 
The present study was conducted to compare the 
effects of Propofol and Isoflurane on the inflammatory 
cytokines serum levels (IL-6, IL-1 and TNF-α) in 
patients undergoing craniotomy due to supratentorial 
brain tumors, showing anesthesia with Propofol 
significantly reduces serum levels of IL-6, IL-1 and 
TNF-α compared to Isoflurane.  
Cytokines are a group of inflammatory 
mediators activated in cascades, having stimulatory or 
inhibitory effects on each other (22). The inflammatory 
cytokines enter the brain in a variety of ways. These 
cytokines can cross the blood brain barrier and link to 
receptors associated with afferent fibers in peripheral 
nerves. They are also produced in the brain by active 
microglia, astrocytes and neurons (22, 23). 
Some study had results in parallel by our results. 
Citerio et al. examined the level of neuroendocrine 
stress response during non-emergency craniotomy and 
showed that intravascular anesthetics modulated 
inflammatory responses caused by intraoperative 
stresses (24). Liu et al. also confirmed a significant 
decrease in the number of immune cells after induction 
of anesthesia by intravascular anesthetics in candidates 
for the craniotomy (11). Marik et al. found that the 
Propofol was able to decrease the production level of 
pre-inflammatory cytokines and increase the 
production of nitric oxide and could prevent neutrophil 
activity (25). In a study of Ye et al, in vitro use of 
Propofol completely impeded lipopolysaccharide 
(LPS)-related activation of microglia and the 
production of pro-inflammatory cytokines (17). 
The present study also revealed that both drugs 
decreased the studied cytokine levels, but the 
difference in this decrease was significantly higher in 
the patients under the anesthesia with Propofol 
compared to the Isoflurane group. This difference 
indicates that the Propofol was more effective in 
controlling inflammation following surgery compared 
to the Isoflurane. Liu et al. proved the anti-
inflammatory effects of the Propofol in animal models 
(11). Ding et al. also underlined that the Propofol was 
associated with a decrease in the production of IL-1 
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and TNF-α in animal models of brain trauma due to a decrease in AQP-4 gene expression (26). Sheng et al. 
 
Figure 1.Flow diagram of the study. 
Table 1: Baseline demographics and surgical procedure. 
 
 P I P value 
Age 48.06±5.79 47.80 ±5.54  0.85 
BMI 25.96±1.7 15.36±1.5 0.17 
Gender(M/F) 19/11 13/17 0.19 
ASA(I/II) 20/10 15/15 0.29 
The results are expressed as mean ± SD or number of patients 
The differences between groups were not significant (p > 0.05) 
ASA: American Society of Anesthesiologists 
 
Table 2: Intraoperative variables. 
 
 P I P value 
Duration of procedure 
(min) 
213.5±26.5 204.5±16.3 0.11 
Duration of anesthesia 
(min) 
230.1±15.7 229±14.5 0.76 
Intravenous fluid (ml) 1275±170.7 1180±148.3 0.40 
Urine volume (ml) 723±23.3 735±5.0 0.42 
Mean systolic 
Pressure(mm/Hg) 
115±7.0 110±8.1 0.50 
Mean Diastolic 
Pressure(mm/Hg) 
76.66±5.7 71.66±2.8 0.25 
The results are expressed as mean ± SD or number of patients 
The differences between groups were not significant (p > 0.05) 
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also expressed that the Propofol in patients undergoing 
craniotomy following hypertension and intracerebral 
hemorrhage reduced TNF-α levels in comparison with 
the control group, as well as the Propofol resulted in a 
significant decrease in the IL-6 level compared to the 
control group (27). Berger et al. also stated that the 
Propofol and the Isoflurane in the patients undergoing 
craniotomy reduced postoperatively TNF-α level in 
both groups, but there was no significant difference in 
the reduction level between the two groups (28). 
In-vitro studies have highlighted that the 
Propofol affects the HMGB1 gene expression level in 
macrophage cells by lipopolysaccharides and reduces 
the release of IL-6 and TNF-α, justifying the anti-
inflammatory effects of the Propofol during the 
craniotomy. The HMGB1 is a DNA-binding protein 
that conserves the nucleosome structure and modulates 
the gene expression. Recent studies have reported that 
this protein has pro-inflammatory effects during 
inflammatory responses (29). This protein through 
activating macrophages helps secreting various 
inflammatory cytokines, including IL-1, IL-6, TNF-α 
and nitric acid (30). On the other hand, the effects of 
Isoflurane on the inflammatory cytokines have been 
confirmed in the animal models. The animal models 
showed that 1.4% Isoflurane decrease the level of IL-
1, IL-6 and IFN-α (31). Another study stated that 1.4% 
Isoflurane suppressed TNF-α in the LPS-induced 
models (32).  
However, human models showed contradictory 
results about the effect of Isoflurane on the 
inflammatory cytokines. Karabivik et al. claimed that 
the Isoflurane might be involved in elective abdominal 
surgery with damage to DNA following inflammatory 
system activity. In the same way, other studies on 
patients who undergoing cholecystectomy and 
hysterectomy found that the Isoflurane could increase 
inflammatory responses (33-35) . 
In contrast, and in contradiction to the results of 
previous studies, ENT surgical procedures indicated 
that the Isoflurane had no effect on the level of 
inflammatory reactions and even reduced the level of 
IL-6 in some cases (36-38). 
Based on the results of recent studies it seems 
that, the effect of Isoflurane and Propofol is highly 
dependent on the type of surgery, and it is necessary to 
select any of these drugs in accordance with the type of 
surgery. 
It is important to note that changes in the level 
of cytokines from the baseline level can occur due to 
multiple causes, including various diseases, drug 
therapies, type of surgery or postoperative 
complications. 
During neurosurgical surgery, the inflammation 
occurs mainly due to brain damage for several causes, 
such as brain tissue damage and hemodynamic 
alteration in the body, which affect the normal 
structure of the brain (39). Therefore, it is 
recommended that subsequent studies examine the 
effect of other background factors affecting the level of 
inflammatory cytokines. 
Conclusion 
The results of the current study showed no 
significant differences between these variables in the 
two groups of anesthesia. In general, our findings 
indicated that use of Propofol in the elective 
craniotomy in treating the supratentorial brain tumors, 
compared to the Isoflurane, significantly and more 
effectively modulates the inflammatory responses in 
the patients, highlighting the neuroprotective effect of 
this drug during the neurosurgeries. 
According to the results, it could be concluded 
that the anti-inflammatory cytokines, such as IL-1, IL-
6 and TNF-α, after surgery showed significantly low 
increased serum levels in the Propofol-induced 
anesthesia compared to the Isoflurane-induced 
anesthesia. This reflects the fact that the Propofol-
Table 3: Interleukin 1, 6 and TNF α serum levels at the end of surgery 
P value P I  
0.001 8473.25 ± 733.69 11426.0 ± 683.93 IL-1 
0.04 8028.50 ± 109.68 11168.0 ± 782.0 IL-6 
0.01 3.62 ± 0.96 5.98 ± 1.12 TNF-α 
I: Isoflurane group, P: Propofol group 
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induced anesthesia can have anti-inflammatory effects, 
followed by protective effects on the nervous system. 
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